Immunopharmacology And Immunotoxicology

Immunopharmacology And Immunotoxicology

免疫药理学和免疫毒理学

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Immunopharmacology And Immunotoxicology》是由Informa Healthcare出版社于1987年创办的英文国际期刊(ISSN: 0892-3973,E-ISSN: 1532-2513),该期刊长期致力于毒理学领域的创新研究,主要研究方向为医学-毒理学。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA未开放获取模式(OA占比0%),以发表毒理学领域等方向的原创性研究为核心(研究类文章占比86.44%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在59篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Immunopharmacology And Immunotoxicology审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约59篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 59 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
TOXICOLOGY 毒理学 IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学
3区 4区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学
4区 4区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q3 108 / 181

40.6%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 147 / 354

58.6%

学科:TOXICOLOGY SCIE Q2 49 / 106

54.2%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q2 85 / 181

53.31%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 162 / 354

54.38%

学科:TOXICOLOGY SCIE Q2 53 / 106

50.47%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.4 SJR:0.68 SNIP:0.679
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Toxicology Q2 58 / 133

56%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q2 141 / 313

55%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Immunology and Allergy Q2 115 / 233

50%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Immunology Q3 133 / 236

43%

期刊发文

  • Xanthones from securidaca inappendiculata antagonizes the anti-rheumatic effect of methotrexate by inhibiting reduced folate carrier 1

    Author: Zhang, Sa-sa; Wu, Yi-jin; Pan, Shu; Wang, Qi-hai; Chen, Wen-gang; Wang, Zhong-fang; Xu, Jin-ying; Zuo, Jian; Yin, Qin

    Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 16-25. DOI: 10.1080/08923973.2022.2103707

  • A comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis

    Author: Liu, Tong; Jiang, Shuai; Teng, Xue; Zhong, Lu; Liu, Mengmeng; Jin, Yao; Dong, Mei

    Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 1-9. DOI: 10.1080/08923973.2022.2112222

  • Corynoline ameliorates dextran sulfate sodium-induced colitis in mice by modulating Nrf2/NF-kappa B pathway

    Author: Zhang, Haihua; Lang, Wuying; Li, Sufen; Xu, Chao; Wang, Xiumin; Li, Yunyu; Zhang, Zhiqiang; Wu, Tonglei; Feng, Minshan

    Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 26-34. DOI: 10.1080/08923973.2022.2112218

  • Sulforaphane suppresses skin squamous cell carcinoma cells proliferation through miR-199a-5p/Sirt1/CD44ICD signaling pathway

    Author: Zhang, Yang; Ai, Ping; Chen, Shang-zhou; Lei, Shu-ying

    Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 52-60. DOI: 10.1080/08923973.2022.2112221

  • Monensin synergizes with chemotherapy in uveal melanoma through suppressing RhoA

    Author: Zeng, Chaoxia; Long, Mingxia; Lu, Ying

    Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 35-42. DOI: 10.1080/08923973.2022.2112219

  • alpha-Cyperone ameliorates depression in mammary gland hyperplasia and chronic unpredictable mild stress rat by regulating hormone, inflammation, and oxidative stress

    Author: Qiao, Nan; Wang, Qinnan; Tao, Ye; Wu, Jinna; Fang, Yong; Ni, Yusheng; Ding, Xiaowen

    Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 73-82. DOI: 10.1080/08923973.2022.2115925

  • Protective effects of Tripterygium glycoside on IL-1 beta-induced inflammation and apoptosis of rat chondrocytes via microRNA-216a-5p/TLR4/NF-kappa B axis

    Author: Huang, Zhen; Song, Shuanglin; Zhang, Di; Bian, Zhenyu; Han, Jinsheng

    Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 1, pp. 61-72. DOI: 10.1080/08923973.2022.2115924

  • Sestrin2 suppresses ferroptosis to alleviate septic intestinal inflammation and barrier dysfunction

    Author: Liu, Wei; Xu, Chanchan; Zou, Zhiqiang; Weng, Qinyong; Xiao, Ying

    Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2023; Vol. 45, Issue 2, pp. 123-132. DOI: 10.1080/08923973.2022.2121927